Your browser doesn't support javascript.
loading
KIF18B promotes tumor progression through activating the Wnt/ß-catenin pathway in cervical cancer.
Wu, Yaqin; Wang, Anpeng; Zhu, Biqing; Huang, Jian; Lu, Emei; Xu, Hanzi; Xia, Wenjie; Dong, Gaochao; Jiang, Feng; Xu, Lin.
Afiliación
  • Wu Y; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Wang A; Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Zhu B; The Fourth Clinical College of Nanjing Medical University, Nanjing, People's Republic of China.
  • Huang J; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Lu E; The Fourth Clinical College of Nanjing Medical University, Nanjing, People's Republic of China.
  • Xu H; Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Xia W; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Dong G; Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Jiang F; The Fourth Clinical College of Nanjing Medical University, Nanjing, People's Republic of China.
  • Xu L; Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Onco Targets Ther ; 11: 1707-1720, 2018.
Article en En | MEDLINE | ID: mdl-29636620
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda